As shown in Table 2 , five-year OS rates were higher in the LCRT group compared to the SCRT group; however, the difference did not reach statistical significance (77.3% vs. 65.6%, P = 0.4).
← all excerpts
Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: long-term results of a randomized controlled trial.
2
0.4000
0.4000
The sentences
Conclusion DFS showed a trend in favor of the LCRT group, with LCRT being significantly superior among men, patients under 60, and cT4 stage.